Remove tag open-access
article thumbnail

Grand Rounds May 5, 2023: All of Us Research Program: Improving Health Through Diverse Technology, Huge Cohorts, and Precision Medicine (Joshua C. Denny, MD, MS)

Rethinking Clinical Trials

Participation in All of Us is open to all and reflects the rich diversity of the U.S. Participants have access to their information, data will be access broadly for research purposes, and security and privacy will be of highest importance. The Researcher Workbench is a cloud-based central resource with a passport access model.

Medicine 130
article thumbnail

Dynamic Reports – A How-to Guide

Cloudbyz

Open reports with a click of a button and dynamically pass parameters to report filters! Purpose: This blog will show you how to create dynamic contextual reports that users can access directly from the record, (ie: Account or Opportunity). The ‘ fv(n) ’ tag is used for lighting reports and ‘ pv(n) ’ tag is used for classic reports.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What challenges does the advanced therapies sector face? 

Drug Discovery World

Dr Naldini open new doors for cures for otherwise untreatable genetic diseases with the full impact of his work still untapped”, she said. Developing value-based payment models that consider long-term benefits could improve access. Fostering open innovation and collaboration could help address this issue.

article thumbnail

WHO update on Omicron

The Pharma Data

1.1.529 a variant of concern, named Omicron, on the advice of WHO’s Technical Advisory Group on Virus Evolution (TAG-VE). WHO’s TAG-VE will continue to monitor and evaluate the data as it becomes available and assess how mutations in Omicron alter the behaviour of the virus. Recommended actions for countries.

article thumbnail

Immunocore’s Kimmtrak Gets FDA Approval as First Treatment for Rare Eye Cancer and First T Cell Receptor Therapeutic

XTalks

Kimmtrak has a price tag of $18,760 per vial, which amounts to a weekly dose. Immunocore’s commercial chief Ralph Torbay said the company has created a Kimmtrak Connect program to help patients access the therapy irrespective of their financial situation. The median treatment time is about 23 weeks (or 5.3

article thumbnail

Grand Rounds August 18, 2023: Opportunities to Improve Clinical Trials: Draft Revision of the ICH Good Clinical Practice Guideline (E6R3) (Prof Sir Martin Landray, FMedSci; M. Khair ElZarrad, PhD, MPH)

Rethinking Clinical Trials

The field will also need to collaborate on implementation and capacity building, develop responsive and accessible training and avoid all-or-nothing approaches on design and technologies. We need to create a space where this is an open dialogue and these kinds of conversations can happen. We see that as an important part of the future.

article thumbnail

Grand Rounds August 18, 2023: Opportunities to Improve Clinical Trials: Draft Revision of the ICH Good Clinical Practice Guideline (E6R3) (Prof Sir Martin Landray, FMedSci; M. Khair ElZarrad, PhD, MPH; Adrian F. Hernandez, MD, MHS)

Rethinking Clinical Trials

The field will also need to collaborate on implementation and capacity building, develop responsive and accessible training and avoid all-or-nothing approaches on design and technologies. We need to create a space where this is an open dialogue and these kinds of conversations can happen. We see that as an important part of the future.